trial · primary record
INS1201
Duchenne Muscular Dystrophy
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 12 |
| Primary completion | 2028-03-31 |
| Primary endpoint | Parts 1 and 2: Incidence and Severity of Treatment Emergent Adverse Events (TEAEs) |
| Registry ID | NCT06817382 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:44:04.354Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06817382
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.